A decade after Candida auris was discovered, cases have been reported in more than 30 countries around the globe, according to an article on the WPTV website.
To Dr. Tom Chiller, chief of the Centers for Disease Control and Prevention's Mycotic Diseases Branch, the emergence of Candida auris highlights the danger of antimicrobial resistance: the rise of "superbugs."
When it comes to bacteria, drug-resistant infections affect 2 million people a year in the United States, killing at least 23,000, according to the CDC.
And drug-resistant infections more broadly could claim 10 million lives per year around the globe by 2050 -- up from today's 700,000, according to one estimate. "We live in a world covered with antibiotics," Chiller said. "We really need to be thinking hard about how we use those drugs."
Charging Ahead: Incentives Driving EV Charging in Healthcare Facilities
Outpatient Growth and the Future of Healthcare Real Estate
Mount Sinai South Nassau Opens Expanded Emergency Department
Lehigh Valley Health Network to Open Fourth Neighborhood Hospital in 2026
Creating an Emergency Preparedness Plan with NFPA 99